US Stock MarketDetailed Quotes

NRIX Nurix Therapeutics

Watchlist
  • 22.050
  • -0.320-1.43%
Close Nov 22 16:00 ET
1.56BMarket Cap-7603P/E (TTM)

Nurix Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Aug 31, 2024
(Q2)May 31, 2024
(Q1)Feb 29, 2024
(FY)Nov 30, 2023
(Q4)Nov 30, 2023
(Q3)Aug 31, 2023
(Q2)May 31, 2023
(Q1)Feb 28, 2023
(FY)Nov 30, 2022
(Q4)Nov 30, 2022
Total revenue
-31.84%12.59M
-60.58%12.09M
30.74%16.59M
99.31%76.99M
123.49%15.16M
71.13%18.47M
168.33%30.68M
31.85%12.69M
29.84%38.63M
-8.29%6.78M
Operating revenue
-31.84%12.59M
-60.58%12.09M
30.74%16.59M
99.31%76.99M
123.49%15.16M
71.13%18.47M
168.33%30.68M
31.85%12.69M
29.84%38.63M
-8.29%6.78M
Cost of revenue
Gross profit
Operating expense
14.91%67.2M
5.56%60.63M
11.08%61.8M
4.29%232.05M
9.05%60.49M
1.69%58.48M
0.51%57.44M
6.25%55.64M
50.70%222.49M
22.32%55.47M
Selling and administrative expenses
10.31%11.72M
0.27%11.71M
20.14%11.8M
12.91%42.9M
15.08%10.78M
8.98%10.62M
20.97%11.68M
6.43%9.82M
21.78%38M
6.23%9.37M
-General and administrative expense
10.31%11.72M
0.27%11.71M
20.14%11.8M
12.91%42.9M
15.08%10.78M
8.98%10.62M
20.97%11.68M
6.43%9.82M
21.78%38M
6.23%9.37M
Research and development costs
15.93%55.48M
6.90%48.92M
9.14%50.01M
2.52%189.15M
7.82%49.71M
0.20%47.86M
-3.64%45.76M
6.21%45.82M
58.46%184.5M
26.21%46.11M
Operating profit
-36.49%-54.61M
-81.36%-48.54M
-5.28%-45.22M
15.67%-155.06M
6.89%-45.33M
14.35%-40.01M
41.45%-26.77M
-0.49%-42.95M
-55.97%-183.87M
-28.29%-48.69M
Net non-operating interest income expense
89.34%5.74M
64.15%4.08M
70.84%3.79M
216.94%11.12M
71.21%3.38M
200.30%3.03M
692.36%2.49M
951.66%2.22M
326.12%3.51M
568.81%1.97M
Non-operating interest income
89.34%5.74M
64.15%4.08M
70.84%3.79M
216.94%11.12M
71.21%3.38M
200.30%3.03M
692.36%2.49M
951.66%2.22M
326.12%3.51M
568.81%1.97M
Other net income (expense)
Income before tax
-32.16%-48.87M
-83.12%-44.46M
-1.71%-41.43M
20.19%-143.95M
10.19%-41.96M
19.09%-36.98M
46.53%-24.28M
4.23%-40.73M
-54.07%-180.36M
-24.06%-46.72M
Income tax
82K
90K
90K
0
0
0
Net income
-32.38%-48.96M
-83.49%-44.55M
-1.93%-41.52M
20.19%-143.95M
10.19%-41.96M
19.09%-36.98M
46.53%-24.28M
4.23%-40.73M
-53.90%-180.36M
-23.91%-46.72M
Net income continuous Operations
-32.38%-48.96M
-83.49%-44.55M
-1.93%-41.52M
20.19%-143.95M
10.19%-41.96M
19.09%-36.98M
46.53%-24.28M
4.23%-40.73M
-53.90%-180.36M
-23.91%-46.72M
Minority interest income
Net income attributable to the parent company
-32.38%-48.96M
-83.49%-44.55M
-1.93%-41.52M
20.19%-143.95M
10.19%-41.96M
19.09%-36.98M
46.53%-24.28M
4.23%-40.73M
-53.90%-180.36M
-23.91%-46.72M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-32.38%-48.96M
-83.49%-44.55M
-1.93%-41.52M
20.19%-143.95M
10.19%-41.96M
19.09%-36.98M
46.53%-24.28M
4.23%-40.73M
-53.90%-180.36M
-23.91%-46.72M
Basic earnings per share
1.47%-0.67
-57.78%-0.71
-1.33%-0.76
28.57%-2.65
11.49%-0.77
24.44%-0.68
55.45%-0.45
21.05%-0.75
-35.90%-3.71
-2.35%-0.87
Diluted earnings per share
1.47%-0.67
-57.78%-0.71
-1.33%-0.76
28.57%-2.65
11.49%-0.77
24.44%-0.68
55.45%-0.45
21.05%-0.75
-35.90%-3.71
-2.35%-0.87
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Aug 31, 2024(Q2)May 31, 2024(Q1)Feb 29, 2024(FY)Nov 30, 2023(Q4)Nov 30, 2023(Q3)Aug 31, 2023(Q2)May 31, 2023(Q1)Feb 28, 2023(FY)Nov 30, 2022(Q4)Nov 30, 2022
Total revenue -31.84%12.59M-60.58%12.09M30.74%16.59M99.31%76.99M123.49%15.16M71.13%18.47M168.33%30.68M31.85%12.69M29.84%38.63M-8.29%6.78M
Operating revenue -31.84%12.59M-60.58%12.09M30.74%16.59M99.31%76.99M123.49%15.16M71.13%18.47M168.33%30.68M31.85%12.69M29.84%38.63M-8.29%6.78M
Cost of revenue
Gross profit
Operating expense 14.91%67.2M5.56%60.63M11.08%61.8M4.29%232.05M9.05%60.49M1.69%58.48M0.51%57.44M6.25%55.64M50.70%222.49M22.32%55.47M
Selling and administrative expenses 10.31%11.72M0.27%11.71M20.14%11.8M12.91%42.9M15.08%10.78M8.98%10.62M20.97%11.68M6.43%9.82M21.78%38M6.23%9.37M
-General and administrative expense 10.31%11.72M0.27%11.71M20.14%11.8M12.91%42.9M15.08%10.78M8.98%10.62M20.97%11.68M6.43%9.82M21.78%38M6.23%9.37M
Research and development costs 15.93%55.48M6.90%48.92M9.14%50.01M2.52%189.15M7.82%49.71M0.20%47.86M-3.64%45.76M6.21%45.82M58.46%184.5M26.21%46.11M
Operating profit -36.49%-54.61M-81.36%-48.54M-5.28%-45.22M15.67%-155.06M6.89%-45.33M14.35%-40.01M41.45%-26.77M-0.49%-42.95M-55.97%-183.87M-28.29%-48.69M
Net non-operating interest income expense 89.34%5.74M64.15%4.08M70.84%3.79M216.94%11.12M71.21%3.38M200.30%3.03M692.36%2.49M951.66%2.22M326.12%3.51M568.81%1.97M
Non-operating interest income 89.34%5.74M64.15%4.08M70.84%3.79M216.94%11.12M71.21%3.38M200.30%3.03M692.36%2.49M951.66%2.22M326.12%3.51M568.81%1.97M
Other net income (expense)
Income before tax -32.16%-48.87M-83.12%-44.46M-1.71%-41.43M20.19%-143.95M10.19%-41.96M19.09%-36.98M46.53%-24.28M4.23%-40.73M-54.07%-180.36M-24.06%-46.72M
Income tax 82K90K90K000
Net income -32.38%-48.96M-83.49%-44.55M-1.93%-41.52M20.19%-143.95M10.19%-41.96M19.09%-36.98M46.53%-24.28M4.23%-40.73M-53.90%-180.36M-23.91%-46.72M
Net income continuous Operations -32.38%-48.96M-83.49%-44.55M-1.93%-41.52M20.19%-143.95M10.19%-41.96M19.09%-36.98M46.53%-24.28M4.23%-40.73M-53.90%-180.36M-23.91%-46.72M
Minority interest income
Net income attributable to the parent company -32.38%-48.96M-83.49%-44.55M-1.93%-41.52M20.19%-143.95M10.19%-41.96M19.09%-36.98M46.53%-24.28M4.23%-40.73M-53.90%-180.36M-23.91%-46.72M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -32.38%-48.96M-83.49%-44.55M-1.93%-41.52M20.19%-143.95M10.19%-41.96M19.09%-36.98M46.53%-24.28M4.23%-40.73M-53.90%-180.36M-23.91%-46.72M
Basic earnings per share 1.47%-0.67-57.78%-0.71-1.33%-0.7628.57%-2.6511.49%-0.7724.44%-0.6855.45%-0.4521.05%-0.75-35.90%-3.71-2.35%-0.87
Diluted earnings per share 1.47%-0.67-57.78%-0.71-1.33%-0.7628.57%-2.6511.49%-0.7724.44%-0.6855.45%-0.4521.05%-0.75-35.90%-3.71-2.35%-0.87
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data